Completion of the two-dose recombinant zoster vaccine series in adults 50 years and older.

CONCLUSION: Completion of RZV series appears suboptimal in the early phase of implementation. Despite similar accessibility in a health care system, completion varied by race/ethnicity, socioeconomic status, health status, and care seeking behavior, suggesting areas to target for improvement. PMID: 33441234 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33441234?dopt=Abstract

Source: Vaccine - January 11, 2021 Category: Allergy & Immunology Authors: Ackerson B, Qian L, Sy LS, Bruxvoort K, Wu J, Luo Y, Diaz-Decaro J, Talarico C, Tseng HF Tags: Vaccine Source Type: research